Results 21 to 30 of about 45,169 (292)

Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy

Journal of the International Association of Providers of AIDS Care, 2020
Background: The implication and clinical significance of low-level viremia (LLV) in HIV patients are still not clear. This study aimed to characterize the clinical outcomes and to evaluate whether LLV could predict future virological failure in a well ...
Zied Gaifer MBBS, MD, Mohamed-Rachid Boulassel DEMS, PhD   +1 more
doaj   +1 more source

Early and Late Virologic Failure After Virologic Suppression in HIV-Infected Asian Children and Adolescents [PDF]

JAIDS Journal of Acquired Immune Deficiency Syndromes, 2019
Background: Virologic failure is a major threat to maintaining effective combination antiretroviral therapy, especially for children in need of lifelong treatment. With efforts to expand access to HIV viral load testing, our understanding of pediatric virologic failure is evolving. Setting:
Weiwei, Mu, Adam W, Bartlett, Torsak, Bunupuradah, Kulkanya, Chokephaibulkit, Nagalingeswaran, Kumarasamy, Penh Sun, Ly, Rawiwan, Hansudewechakul, Lam Van, Nguyen, Pagakrong, Lumbiganon, Tavitiya, Sudjaritruk, Thahira A Jamal, Mohamed, Nik Khairulddin Nik, Yusoff, Khanh Huu, Truong, Viet Chau, Do, Moy Siew, Fong, Revathy, Nallusamy, Nia, Kurniati, Dewi Kumara, Wati, Annette H, Sohn, Azar, Kariminia, Fujie, Zhang   +20 more
openaire   +4 more sources

Outcomes of a remote, decentralized health center-based HIV/AIDS antiretroviral program in Zambia, 2003 to 2007 [PDF]

, 2009
A cross-sectional study of patients living with HIV/ AIDS treated during 2003 to 2007 in decentralized, rural health centers in Zambia was performed to measure virological outcomes after 12 months of antiretroviral therapy and identify factors associated
Elema, R, Mills, C, Yun, O, Lokuge, K, Ssonko, C, Nyirongo, N, Mtonga, V, Zulu, H, Tu, D, Verputten, M, O'Brien, D P   +10 more
core   +2 more sources

Low‐level residual viremia and risk of virological failure [PDF]

Journal of the International AIDS Society, 2010
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow ...
Cologni, G, Soavi, L, Leone, S, Valenti, D, Callegaro, A, Gregis, G, Suter, F, Maggiolo, F   +7 more
openaire   +1 more source

Predictors of virological failure among people living with HIV receiving first line antiretroviral treatment in Myanmar: retrospective cohort analysis

AIDS Research and Therapy, 2021
Background Progress toward the global target for 95% virological suppression among those on antiretroviral treatment (ART) is still suboptimal. We describe the viral load (VL) cascade, the incidence of virological failure and associated risk factors ...
Anita Mesic, Alexander Spina, Htay Thet Mar, Phone Thit, Tom Decroo, Annick Lenglet, Moe Pyae Thandar, Thin Thin Thwe, Aung Aung Kyaw, Tobias Homan, Mitchell Sangma, Ronald Kremer, Jane Grieg, Erwan Piriou, Koert Ritmeijer, Josefien Van Olmen, Lutgarde Lynen, Htun Nyunt Oo   +17 more
doaj   +1 more source

The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure. [PDF]

, 2012
Objectives  To determine the improvement in positive predictive value of immunological failure criteria for identifying virological failure in HIV-infected children on antiretroviral therapy (ART) when a single targeted viral load measurement is ...
Calmy, Davies, Davies, Glencross, Jittamala, National Institutes of Health, Orrell, Rewari, Ruel, Schneider, Sigaloff, Stevens, Whiting, WHO, Wilson   +14 more
core   +2 more sources

HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts [PDF]

Infectious Disorders - Drug Targets, 2011
Poor adherence to combined antiretroviral therapy (cART) has been shown to be a major determinant of virologic failure, emergence of drug resistant virus, disease progression, hospitalizations, mortality, and health care costs. While high adherence levels can be achieved in both resource-rich and resource-limited settings following initiation of cART ...
Nachega J.B., Marconi V.C., van Zyl G.U., Gardner E.M., Preiser W., Hong S.Y., Mills E.J., Gross R.   +7 more
openaire   +2 more sources

Challenges and Opportunities for the Implementation of Virological Testing in resource-limited settings [PDF]

, 2012
Though the advantages of routine virological monitoring for patients on anti-retroviral therapy have been established, cost and complexity limit its full implementation.
Bartlett, Department of Health and Human Services, Emmanuel Fajardo, Hamers, Hamers, Helen Bygrave, Jani, Kerschberger, Laurent, Murtagh, Médecins Sans Frontières, Médecins Sans Frontières, Nathan Ford, Orrell, Orrell, Orrell, Oyomopito, Teri Roberts, UNAIDS, Médecins Sans Frontières, World Health Organization, World Health Organization, World Health Organization, World Health Organization, UNAIDS   +22 more
core   +3 more sources

Virological failure of patients on maraviroc-based antiretroviral therapy [PDF]

Journal of Antimicrobial Chemotherapy, 2015
Abstract Objectives Virological failure (VF) in patients on maraviroc-based treatment has been associated with altered HIV tropism and resistance to maraviroc. This multicentre study aimed to characterize VF in patients treated with maraviroc. Methods
Stéphanie Raymond, Anne Maillard, Corinne Amiel, Gilles Peytavin, Mary Anne Trabaud, Delphine Desbois, Pantxika Bellecave, Constance Delaugerre, Cathia Soulie, Anne Geneviève Marcelin, Diane Descamps, Jacques Izopet, S. Reigadas, P. Bellecave, P. Pinson-Recordon, H. Fleury, B. Masquelier, A. Signori-Schmuck, P. Morand, L. Bocket, L. Mouna, P. André, J. C. Tardy, M. A. Trabaud, D. Descamps, C. Charpentier, G. Peytavin, F. Brun-Vézinet, S. Haim-Boukobza, A. M. Roques, C. Soulié, S. Lambert-Niclot, I. Malet, M. Wirden, S. Fourati, A. G. Marcelin, V. Calvez, P. Flandre, L. Assoumou, D. Costagliola, L. Morand-Joubert, C. Delaugerre, V. Schneider, C. Amiel, G. Giraudeau, A. Maillard, F. Nicot, J. Izopet   +47 more
openaire   +3 more sources

Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort [PDF]

, 2019
Introduction: Concerns about dolutegravir (DTG) tolerability in the real-life setting have recently arisen. We aimed to estimate the risk of treatment discontinuation and virological failure of DTG-based regimens from a large cohort of HIV-infected ...
Abeli C., Acinapura R., alungo A., Andreoni M., Angarano G., Antinori A., aracino A., atini A., azzarin A., Bagella P., Bai F., Baldelli F., Baldin G., Balotta C., Bandera A., Barocci V., Bassetti M., Blanc P., Bobbio N., Bonfanti P., Bonora S., Borderi M., Borgia G., Cacopardo B., Calcagno A., Capetti A., Capobianchi M. R., Capozzi M., Caramello P., Carletti F., Carrara S., Cascio A., Cassola G., Castagna A., Castelli F., Castelnuovo F., Cattelan A. M., Cauda R., Ceccherini-Silberstein F., Ceccherini-Silberstein F., Cecchetto M., Celesia B., Chiodera A., Cicalini S., Cingolani A., Cinque P., Colomba C., Costantini A., Cozzi-Lepri A., Cozzi-Lepri A., Cristaudo A., d'Arminio Monforte A., De Luca A., Di Biagio A., Di Caro A., Di Giuli C., Di Martino F., Di Perri G., Esposito V., Fabrizio C., Falasca K., Fanti I., Fontana Del Vecchio R., Francisci D., Galli L., Galli M., Gentile I., Giacometti I. A., Gianotti N., Girardi E., Gori A., Graziano S., Guaraldi G., i V., Iaiani G., Iardino R., Ippolito G., Lapadula G., lessandrini A., Lichtner M., Lo Caputo S., Lorenzini P., Lorenzotti S., Macchia M., Maddaloni L., Madeddu G., Maggiolo F., Maggiolo F., Magnani G., Manfrin V., Marchetti G., Marinello S., Mastrorosa I., Mazzarello G., Menzaghi B., Migliorino C., Milini P., Minardi C., Moioli M. C., Molteni C., Mondi A., Monno L., Mussini C., Nozza S., Nunnari G., ondero A., Orofino G. C., Pan A., Parruti G., Pellicano G., Pellizzer G., Perno C. F., Petrone F., Piolini R., Plazzi M. M., Pozzetto I., Prota G., Puoti M., Puzzolante C., Quartu S., Quiros Roldan E., Rezza G., Ridolfo A. L., Rivano Capparucia M., Rizzardini G., Rodano' A., Rossetti B., Rossotti R., Rusconi S., Rusconi S., Salpietro S., Sangiovanni V., Santoro M. M., Sarmati L., Savinelli S., Schiaroli E., Sciandra M., Segala D., Sighinolfi L., Sozio F., Starnini G., Suardi C., Tavelli A., Tavelli A., Tincati C., Truffa S., Ursitti M. A., Vecchiet J., Vergori A., Verucchi G., Viale P., Vichi F., Viscoli C., Viviani F., von Schloesser F., Vullo V.   +155 more
core   +4 more sources